Identification and Clarification of the Role of Key Active Site Residues in Bacterial Glutathione S-Transferase Zeta/Maleylpyruv
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
On the Active Site Thiol of Y-Glutamylcysteine Synthetase
Proc. Natl. Acad. Sci. USA Vol. 85, pp. 2464-2468, April 1988 Biochemistry On the active site thiol of y-glutamylcysteine synthetase: Relationships to catalysis, inhibition, and regulation (glutathione/cystamine/Escherichia coli/kidney/enzyme inactivation) CHIN-SHIou HUANG, WILLIAM R. MOORE, AND ALTON MEISTER Cornell University Medical College, Department of Biochemistry, 1300 York Avenue, New York, NY 10021 Contributed by Alton Meister, December 4, 1987 ABSTRACT y-Glutamylcysteine synthetase (glutamate- dithiothreitol, suggesting that cystamine forms a mixed cysteine ligase; EC 6.3.2.2) was isolated from an Escherichia disulfide between cysteamine and an enzyme thiol (15). coli strain enriched in the gene for this enzyme by recombinant Inactivation of the enzyme by the L- and D-isomers of DNA techniques. The purified enzyme has a specific activity of 3-amino-1-chloro-2-pentanone, as well as that by cystamine, 1860 units/mg and a molecular weight of 56,000. Comparison is prevented by L-glutamate (14). Treatment of the enzyme of the E. coli enzyme with the well-characterized rat kidney with cystamine prevents its interaction with the sulfoxi- enzyme showed that these enzymes have similar catalytic prop- mines. Titration of the enzyme with 5,5'-dithiobis(2- erties (apparent Km values, substrate specificities, turnover nitrobenzoate) reveals that the enzyme has a single exposed numbers). Both enzymes are feedback-inhibited by glutathione thiol that reacts with this reagent without affecting activity but not by y-glutamyl-a-aminobutyrylglycine; the data indicate (16). 5,5'-Dithiobis(2-nitrobenzoate) does not interact with that glutathione binds not only at the glutamate binding site but the thiol that reacts with cystamine. -
Molecular Markers of Serine Protease Evolution
The EMBO Journal Vol. 20 No. 12 pp. 3036±3045, 2001 Molecular markers of serine protease evolution Maxwell M.Krem and Enrico Di Cera1 ment and specialization of the catalytic architecture should correspond to signi®cant evolutionary transitions in the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Box 8231, St Louis, history of protease clans. Evolutionary markers encoun- MO 63110-1093, USA tered in the sequences contributing to the catalytic apparatus would thus give an account of the history of 1Corresponding author e-mail: [email protected] an enzyme family or clan and provide for comparative analysis with other families and clans. Therefore, the use The evolutionary history of serine proteases can be of sequence markers associated with active site structure accounted for by highly conserved amino acids that generates a model for protease evolution with broad form crucial structural and chemical elements of applicability and potential for extension to other classes of the catalytic apparatus. These residues display non- enzymes. random dichotomies in either amino acid choice or The ®rst report of a sequence marker associated with serine codon usage and serve as discrete markers for active site chemistry was the observation that both AGY tracking changes in the active site environment and and TCN codons were used to encode active site serines in supporting structures. These markers categorize a variety of enzyme families (Brenner, 1988). Since serine proteases of the chymotrypsin-like, subtilisin- AGY®TCN interconversion is an uncommon event, it like and a/b-hydrolase fold clans according to phylo- was reasoned that enzymes within the same family genetic lineages, and indicate the relative ages and utilizing different active site codons belonged to different order of appearance of those lineages. -
Crystallography Captures Catalytic Steps in Human Methionine Adenosyltransferase Enzymes
Crystallography captures catalytic steps in human methionine adenosyltransferase enzymes Ben Murraya,b, Svetlana V. Antonyuka, Alberto Marinab, Shelly C. Luc, Jose M. Matod, S. Samar Hasnaina,1, and Adriana L. Rojasb,1 aMolecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZX, England; bStructural Biology Unit, Center for Cooperative Research in Biosciences, 48160 Derio, Spain; cDivision of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and dCIC bioGUNE, CIBERehd, Parque Tecnologico Bizkaia, 801A-1.48160 Derio, Spain Edited by Gregory A. Petsko, Weill Cornell Medical College, New York, NY, and approved January 8, 2016 (received for review June 4, 2015) The principal methyl donor of the cell, S-adenosylmethionine catalytic mechanism (13, 14) in which the reaction is initiated (SAMe), is produced by the highly conserved family of methionine through a nucleophilic attack by the sulfur atom of methionine adenosyltranferases (MATs) via an ATP-driven process. These en- on the C5′ atom of ATP, which produces the intermediate tri- zymes play an important role in the preservation of life, and their polyphosphate (PPPi). Hydrolysis of the PPPi into pyrophos- dysregulation has been tightly linked to liver and colon cancers. We phate (PPi) and orthophosphate (Pi) then occurs (Fig. S1). present crystal structures of human MATα2 containing various bound A common feature of MAT enzymes is a gating loop that α – ligands, providing a “structural movie” of the catalytic steps. High- to flanks the active site (in human MAT 2 residues 113 131), atomic-resolution structures reveal the structural elements of the which has been postulated to act in a dynamic way to allow ac- enzyme involved in utilization of the substrates methionine and cess to the active site. -
Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
pharmaceutics Review Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice Malavika Deodhar 1, Sweilem B Al Rihani 1 , Meghan J. Arwood 1, Lucy Darakjian 1, Pamela Dow 1 , Jacques Turgeon 1,2 and Veronique Michaud 1,2,* 1 Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, FL 32827, USA; [email protected] (M.D.); [email protected] (S.B.A.R.); [email protected] (M.J.A.); [email protected] (L.D.); [email protected] (P.D.); [email protected] (J.T.) 2 Faculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada * Correspondence: [email protected]; Tel.: +1-856-938-8697 Received: 5 August 2020; Accepted: 31 August 2020; Published: 4 September 2020 Abstract: In an ageing society, polypharmacy has become a major public health and economic issue. Overuse of medications, especially in patients with chronic diseases, carries major health risks. One common consequence of polypharmacy is the increased emergence of adverse drug events, mainly from drug–drug interactions. The majority of currently available drugs are metabolized by CYP450 enzymes. Interactions due to shared CYP450-mediated metabolic pathways for two or more drugs are frequent, especially through reversible or irreversible CYP450 inhibition. The magnitude of these interactions depends on several factors, including varying affinity and concentration of substrates, time delay between the administration of the drugs, and mechanisms of CYP450 inhibition. Various types of CYP450 inhibition (competitive, non-competitive, mechanism-based) have been observed clinically, and interactions of these types require a distinct clinical management strategy. This review focuses on mechanism-based inhibition, which occurs when a substrate forms a reactive intermediate, creating a stable enzyme–intermediate complex that irreversibly reduces enzyme activity. -
Spring 2013 Lecture 13-14
CHM333 LECTURE 13 – 14: 2/13 – 15/13 SPRING 2013 Professor Christine Hrycyna INTRODUCTION TO ENZYMES • Enzymes are usually proteins (some RNA) • In general, names end with suffix “ase” • Enzymes are catalysts – increase the rate of a reaction – not consumed by the reaction – act repeatedly to increase the rate of reactions – Enzymes are often very “specific” – promote only 1 particular reaction – Reactants also called “substrates” of enzyme catalyst rate enhancement non-enzymatic (Pd) 102-104 fold enzymatic up to 1020 fold • How much is 1020 fold? catalyst time for reaction yes 1 second no 3 x 1012 years • 3 x 1012 years is 500 times the age of the earth! Carbonic Anhydrase Tissues ! + CO2 +H2O HCO3− +H "Lungs and Kidney 107 rate enhancement Facilitates the transfer of carbon dioxide from tissues to blood and from blood to alveolar air Many enzyme names end in –ase 89 CHM333 LECTURE 13 – 14: 2/13 – 15/13 SPRING 2013 Professor Christine Hrycyna Why Enzymes? • Accelerate and control the rates of vitally important biochemical reactions • Greater reaction specificity • Milder reaction conditions • Capacity for regulation • Enzymes are the agents of metabolic function. • Metabolites have many potential pathways • Enzymes make the desired one most favorable • Enzymes are necessary for life to exist – otherwise reactions would occur too slowly for a metabolizing organis • Enzymes DO NOT change the equilibrium constant of a reaction (accelerates the rates of the forward and reverse reactions equally) • Enzymes DO NOT alter the standard free energy change, (ΔG°) of a reaction 1. ΔG° = amount of energy consumed or liberated in the reaction 2. -
GSTZ1 Deficiency Promotes Hepatocellular Carcinoma
Li et al. Journal of Experimental & Clinical Cancer Research (2019) 38:438 https://doi.org/10.1186/s13046-019-1459-6 RESEARCH Open Access GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway Jingjing Li1,2†, Qiujie Wang1†, Yi Yang1, Chong Lei1, Fan Yang1, Li Liang1, Chang Chen3, Jie Xia1, Kai Wang1* and Ni Tang1* Abstract Background: Glutathione S-transferase zeta 1 (GSTZ1) is the penultimate enzyme in phenylalanine/tyrosine catabolism. GSTZ1 is dysregulated in cancers; however, its role in tumorigenesis and progression of hepatocellular carcinoma (HCC) is largely unknown. We aimed to assess the role of GSTZ1 in HCC and to reveal the underlying mechanisms, which may contribute to finding a potential therapeutic strategy against HCC. Methods: We first analyzed GSTZ1 expression levels in paired human HCC and adjacent normal tissue specimens and the prognostic effect of GSTZ1 on HCC patients. Thereafter, we evaluated the role of GSTZ1 in aerobic glycolysis in HCC cells on the basis of the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). Furthermore, we assessed the effect of GSTZ1 on HCC proliferation, glutathione (GSH) concentration, levels of reactive oxygen species (ROS), and nuclear factor erythroid 2-related factor 2 (NRF2) signaling via gain- and loss- of GSTZ1 function in vitro. Moreover, we investigated the effect of GSTZ1 on diethylnitrosamine (DEN) and carbon tetrachloride (CCl4)induced hepatocarcinogenesis in a mouse model of HCC. Results: GSTZ1 was downregulated in HCC, thus indicating a poor prognosis. GSTZ1 deficiency significantly promoted hepatoma cell proliferation and aerobic glycolysis in HCC cells. Moreover, loss of GSTZ1 function depleted GSH, increased ROS levels, and enhanced lipid peroxidation, thus activating the NRF2-mediated antioxidant pathway. -
Age-Related Changes in Mirna Expression Influence GSTZ1 and Other Drug Metabolizing Enzymes S
Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2020/04/30/dmd.120.090639.DC1 1521-009X/48/7/563–569$35.00 https://doi.org/10.1124/dmd.120.090639 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 48:563–569, July 2020 Copyright ª 2020 by The American Society for Pharmacology and Experimental Therapeutics Age-Related Changes in miRNA Expression Influence GSTZ1 and Other Drug Metabolizing Enzymes s Stephan C. Jahn, Lauren A. Gay, Claire J. Weaver, Rolf Renne, Taimour Y. Langaee,Department of Pharmacotherapy and Translational Research. Peter W. Stacpoole, and Margaret O. James Departments of Medicinal Chemistry (S.C.J., C.J.W., M.O.J.), Pharmacotherapy and Translational Research (T.Y.L.), Medicine (P.W.S.), Biochemistry and Molecular Biology (P.W.S.), and Molecular Genetics and Microbiology (L.A.G., R.R.), University of Florida, Gainesville, Florida Received January 1, 2020; accepted April 7, 2020 ABSTRACT Previous work has shown that hepatic levels of human glutathione miR-376c-3p could downregulate GSTZ1 protein expression. Our Downloaded from transferase zeta 1 (GSTZ1) protein, involved in tyrosine catabolism findings suggest that miR-376c-3p prevents production of GSTZ1 and responsible for metabolism of the investigational drug dichlor- through inhibition of translation. These experiments further our oacetate, increase in cytosol after birth before reaching a plateau understanding of GSTZ1 regulation. Furthermore, our array results around age 7. However, the mechanism regulating this change of provide a database resource for future studies on mechanisms expression is still unknown, and previous studies showed that regulating human hepatic developmental expression. -
9 Glutathione S-Transferases
Enzyme Systems that Metabolise Drugs and Other Xenobiotics. Edited by Costas Ioannides Copyright # 2001 John Wiley & Sons Ltd ISBNs: 0-471-894-66-4 %Hardback); 0-470-84630-5 %Electronic) 9 Glutathione S-transferases Philip J. Sherratt and John D. Hayes University of Dundee, UK Introduction Glutathione S-transferase GST; EC 2.5.1.18) isoenzymes are ubiquitously distributed in nature, being found in organisms as diverse as microbes, insects, plants, ®sh, birds andmammals Hayes andPulford1995). The transferases possess various activities andparticipate in several differenttypes of reaction. Most of these enzymes can catalyse the conjugation of reduced glutathione GSH) with compounds that contain an electrophilic centre through the formation of a thioether bondbetween the sulphur atom of GSH and the substrate Chasseaud 1979; Mannervik 1985). In addition to conjugation reactions, a number of GST isoenzymes exhibit other GSH-dependent catalytic activities including the reduction of organic hydroperoxides Ketterer et al. 1990) andisomerisation of various unsaturatedcompoundsBenson et al. 1977; Jakoby andHabig 1980). These enzymes also have several non-catalytic functions that relate to the sequestering of carcinogens, intracellular transport of a wide spectrum of hydrophobic ligands, and modulation of signal transduction pathways Listowsky 1993; Adler et al. 1999; Cho et al. 2001). Glutathione S-transferases represent a complex grouping of proteins. Two entirely distinct superfamilies of enzyme have evolved that possess transferase activity Hayes andStrange 2000). The ®rst enzymes to be characterisedwere the cytosolic, or soluble, GSTs BoylandandChasseaud1969; Mannervik 1985). To dateat least 16 members of this superfamily have been identi®ed in humans Board et al. 1997, 2000; Hayes and Strange 2000). -
Dmd.120.000143.Full.Pdf
DMD Fast Forward. Published on September 1, 2020 as DOI: 10.1124/dmd.120.000143 This article has not been copyedited and formatted. The final version may differ from this version. Drug Metabolism and Disposition Exposure of Rats to Multiple Oral Doses of Dichloroacetate Results in Upregulation of Hepatic GSTs and NQO1 Edwin J. Squirewell, Ricky Mareus, Lloyd P. Horne, Peter W. Stacpoole, and Margaret O. James Downloaded from Department of Medicinal Chemistry (E.J.S., R.M., M.O.J.), Department of Medicine (L.P.H., P.W.S.), and Department of Biochemistry and Molecular Biology (P.W.S.), University of Florida, Gainesville FL dmd.aspetjournals.org at ASPET Journals on October 1, 2021 1 DMD Fast Forward. Published on September 1, 2020 as DOI: 10.1124/dmd.120.000143 This article has not been copyedited and formatted. The final version may differ from this version. Running title: Repeated DCA dosing in Rats Increases Hepatic GSTs and NQO1 Address correspondence to: Dr. Margaret O. James, Department of Medicinal Chemistry, University of Florida College of Pharmacy, 1345 Center Drive, Gainesville, FL 32610. Tel: 352-273-7707. Email: [email protected] Downloaded from Number of text pages: 16 Number of tables: 3 Number of figures: 3 dmd.aspetjournals.org Number of references: 77 Number of words in the Abstract: 250 Number of words in Introduction: 657 at ASPET Journals on October 1, 2021 Number of words in Discussion: 1512 Abbreviations: DCA, dichloroacetate; DCPIP, 2,6-dichlorophenolindophenol; DCNB, 1,2-dichloro-4- nitrobenzene; CDNB, 1-chloro-2,4-dinitrobenzene, NQO1, NAD(P)H dehydrogenase [quinone] 1; NBD-Cl, 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole; GCLC, glutamylcysteine ligase complex; GSS, glutathione synthetase; GSH, glutathione; GSTZ1, glutathione transferase zeta 1; MAAI, maleylacetoacetate isomerase; PDK, pyruvate dehydrogenase kinase; PDC, pyruvate dehydrogenase complex; ROS, reactive oxygen species; S.D., standard deviation. -
Disruption of GSTZ1 Gene by Large Genetic Alteration in Oryza Glaberrima
Breeding Science 54 : 67-73 (2004) Disruption of GSTZ1 Gene by Large Genetic Alteration in Oryza glaberrima Tokuji Tsuchiya and Ikuo Nakamura* Graduate School of Science and Technology, Chiba University, 648 Matsudo, Matsudo, Chiba 271-8510, Japan After the completion of the genome sequencing project Introduction of common rice (Oryza sativa L.), comparative genomic studies between rice and related species became impor- Glutathione S-transferases (GSTs; EC 2.5.1.18) are tant to reveal the function of each gene. The rice ge- ubiquitous and abundant detoxifying enzymes in all the organ- nome contains two copies of the gene encoding zeta class isms, such as bacteria, fungi, animals and plants. Recently, glutathione S-transferase (GSTZ) that is reported to be plant GSTs have been classified into four different classes, the enzyme in the catabolic pathway of tyrosine and phi, tau, theta and zeta, based on amino acid sequence simi- phenylalanine. Two GSTZ genes of O. sativa, OsGSTZ1 larity and gene structure (Dixon et al. 1998, Edward et al. and OsGSTZ2, display a tandem arrangement. Up- 2000). The phi and tau GST genes are plant-specific and com- stream OsGSTZ1 gene is constitutively expressed, pose large multi-gene families, whereas the theta and zeta whereas the downstream OsGSTZ2 gene is inducible by GST genes have a few copies. The zeta class GST (GSTZ) stresses. We analyzed the expression of the GSTZ gene genes are present as one or two copies in every plant genome in the African cultivated species O. glaberrima and wild studied, such as A. thaliana, maize, soybean, carnation and species O. -
The Crotonase Superfamily: Divergently Related Enzymes That Catalyze Different Reactions Involving Acyl Coenzyme a Thioesters
Acc. Chem. Res. 2001, 34, 145-157 similar three-dimensional architectures. In each protein, The Crotonase Superfamily: a common structural strategy is employed to lower the Divergently Related Enzymes free energies of chemically similar intermediates. Catalysis of the divergent chemistries is accomplished by both That Catalyze Different retaining those functional groups that catalyze the com- mon partial reaction and incorporating new groups that Reactions Involving Acyl direct the intermediate to new products. Indeed, as a Coenzyme A Thioesters specific example, the enolase superfamily has served as a paradigm for the study of catalytically diverse superfami- HAZEL M. HOLDEN,*,³ lies.3 The active sites of proteins in the enolase superfamily MATTHEW M. BENNING,³ are located at the interfaces between two structural TOOMAS HALLER,² AND JOHN A. GERLT*,² motifs: the catalytic groups are positioned in conserved Departments of Biochemistry, University of Illinois, regions at the ends of the â-strands forming (R/â) 8-barrels, Urbana, Illinois 61801, and University of Wisconsin, while the specificity determinants are found in flexible Madison, Wisconsin 53706 loops in the capping domains formed by the N- and Received August 9, 2000 C-terminal portions of the polypeptide chains. While the members of the enolase superfamily share similar three- ABSTRACT dimensional architectures, they catalyze different overall Synergistic investigations of the reactions catalyzed by several reactions that share a common partial reaction: abstrac- members of an enzyme superfamily provide a more complete tion of an R-proton from a carboxylate anion substrate understanding of the relationships between structure and function than is possible from focused studies of a single enzyme alone. -
A Thesis Entitled Identification and Characterization of a Zebrafish
A Thesis Entitled Identification and Characterization of A Zebrafish Glutathione S-Transferase Pi By Maryam S Abunnaja Submitted to the Graduate Faculty as a Partial Fulfillment of the Requirement for the Master of Science Degree in Pharmacology and Toxicology Dr. Ming-Cheh Liu, Committee Chair Dr. Ezdihar Hassoun, Committee Member Dr. Zahoor Shah, Committee Member Dr. Patricia Komuniecki, Dean College Graduate Studies The University of Toledo May 2013 Copyright 2013, Maryam S Abunnaja This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Identification and Characterization of A Zebrafish Glutathione S-Transferase Pi By Maryam S Abunnaja Submitted to the Graduate Faculty as a Partial Fulfillment of the Requirement for the Master of Science Degree in Pharmacology and Toxicology May 2013 Glutathione S-transferases (GSTs) are a major group of Phase II enzymes involved in the detoxification of certain endogenous compounds such as reactive oxygen species (ROS) generated during metabolism, as well as in the detoxification of xenobiotics including drugs. In recent years, the zebrafish has increasingly been used as a promising animal model for biomedical research. This study is part of an effort to establish the zebrafish as a model for studying GST-mediated glutathione conjugation of xenobiotics. By searching the GenBank database, we have identified sequences encoding fifteen zebrafish GSTs. Using a computer algorithm available at the Genebee website, a dendrogram of the fifteen zebrafish GSTs was generated. A zebrafish GST Pi was subsequently cloned, expressed, and purified. An enzymatic assay for purified GST Pi was established using 1- chloro-2, 4-dinitrobenzene (CDNB) as a substrate.